You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / CE

Can the Mediterranean Diet Avert Pregnancy Complications?

  • Authors: News Author: Marcia Frellick, BSJ; CME Author: Laurie Barclay, MD
  • CME / CE Released: 2/17/2023
  • Valid for credit through: 2/17/2024
Start Activity

  • Credits Available

    Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™

    Nurses - 0.25 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)

    Pharmacists - 0.25 Knowledge-based ACPE (0.025 CEUs)

    Physician Assistant - 0.25 AAPA hour(s) of Category I credit

    IPCE - 0.25 Interprofessional Continuing Education (IPCE) credit

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This activity is intended for obstetricians/gynecologists/women’s health clinicians, cardiologists, diabetologists/endocrinologists, family medicine/primary care clinicians, nurses, pharmacists, physician assistants, and other members of the health care team for pregnant women.

The goal of this activity is for learners to be better able to describe the associations of concordance to a Mediterranean diet pattern around the time of conception with lower risk of developing any adverse pregnancy outcome and individual adverse pregnancy outcomes.

Upon completion of this activity, participants will:

  • Assess the associations of concordance to a Mediterranean diet pattern around the time of conception with lower risk of developing any adverse pregnancy outcome and individual adverse pregnancy outcomes
  • Evaluate the clinical implications of the associations of concordance to a Mediterranean diet pattern around the time of conception with lower risk of developing any adverse pregnancy outcomes and individual adverse pregnancy outcomes
  • Outline implications for the healthcare team


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


News Author

  • Marcia Frellick, BSJ

    Freelance writer, Medscape

    Disclosures

    Marcia Frellick, BSJ, has no relevant financial relationships.

CME Author

  • Laurie Barclay, MD

    Freelance writer and reviewer
    Medscape, LLC

    Disclosures

    Laurie Barclay, MD, has no relevant financial relationships.

Editor/Compliance Reviewer

  • Amanda Jett, PharmD, BCACP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Amanda Jett, PharmD, BCACP, has no relevant financial relationships.

Nurse Planner

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

    For Nurses

  • Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.00 contact hours are in the area of pharmacology.

    Contact This Provider

    For Pharmacists

  • Medscape designates this continuing education activity for 0.25 contact hour(s) (0.025 CEUs) (Universal Activity Number: JA0007105-0000-23-059-H01-P).

    Contact This Provider

  • For Physician Assistants

    Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until 02/17/2024. PAs should only claim credit commensurate with the extent of their participation.

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / CE

Can the Mediterranean Diet Avert Pregnancy Complications?

Authors: News Author: Marcia Frellick, BSJ; CME Author: Laurie Barclay, MDFaculty and Disclosures

CME / CE Released: 2/17/2023

Valid for credit through: 2/17/2024

processing....

Clinical Context

The Centers for Disease Control and Prevention reports that US pregnancy-related mortality has increased steadily during the past 30 years, with significant racial and age disparities. Adverse pregnancy outcome (APOs) are leading risk factors for maternal morbidity/mortality, mandating APO prevention.

Poor diet quality is common among US women periconceptionally, and dietary patterns seldom change significantly from prepregnancy to early pregnancy. Periconceptual diet is therefore an important potential target for reducing APOs. Mediterranean diet has been linked to health and longevity and might help prevent APOs.

Study Synopsis and Perspective

Women in the United States who followed a Mediterranean-style diet (heavy on fresh foods, fish, and olive oil) around the time of conception had lower risk of developing a pregnancy complication, results of a large new study suggest.

The study included 7,798 women who had not given birth before. The group was geographically, racially, and ethnically diverse.

Researchers led by Nour Makarem, PhD, from the Department of Epidemiology, Columbia University, New York, published their results in JAMA Network Open.

“Generally higher intakes of vegetables, fruits, legumes, fish, and whole grains and lower intakes of red and processed meat were associated with lower risk of APOs,” the authors write.

21% Lower Risk for Complications

The investigators found that women in the study, who were part of the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be, which enrolled 10,038 women between October 1, 2010, and September 30, 2013, and scored high on adherence to a Mediterranean diet, had a 21% lower risk of developing any APO than those who had low adherence. And the better the adherence, the lower the risk for adverse outcomes, especially preeclampsia or eclampsia and gestational diabetes, the researchers write.

The research team also studied how following the diet correlated with gestational high blood pressure, preterm birth, delivery of a small-for-gestational-age infant, and stillbirth.

Women were scored on consumption of 9 components: vegetables (excluding potatoes), fruits, nuts, whole grains, legumes, fish, monounsaturated to saturated fat ratio, red and processed meats, and alcohol.

No Differences By Race, Ethnicity, or Body Mass Index

There were no differences in adverse pregnancy outcomes by race, ethnicity, or the woman’s body mass index before pregnancy, but associations were stronger in the women who were aged 35 years or older, according to the article.

The authors point out that the women in the study had access to prenatal care at a large academic medical center during their first 3 months of pregnancy, so the study may actually underestimate the importance of the diet in the pregnancy outcomes.

Christina Han, MD, division director of maternal-fetal medicine at University of California, Los Angeles, who was not part of the study, said that the results make sense, as the researchers looked at the time of conception, which is a time that reflects the way a person chooses to live their life.

“We know that your health state as you enter pregnancy can significantly affect your outcomes for that pregnancy,” she said. “We’ve known for decades now that a Mediterranean diet is good for just about everybody.”

Unequal Access to Foods on Diet

Dr Han said that although it is great that the researchers were able to confirm the benefit of the Mediterranean diet, it highlights inequity, as lower-income people are not as likely to be able to afford fresh fruits and vegetables and fish.

“This is a call to arms for our food distribution system to even out the big divide in what patients have access to,” Dr Han said.

She noted that most of the women in this study were married, non-Hispanic White, and had higher levels of education, which may make it hard to generalize these results to the general population.

A limitation of the study is that the women were asked to report what they ate themselves, which can be less accurate than when researchers record what is eaten in a controlled setting.

The researchers suggested a next step: “Long-term intervention studies are needed to assess whether promoting a Mediterranean-style diet pattern around the time of conception and throughout pregnancy can prevent APOs.”

Dr Makarem reported receiving grants from the National Institutes of Health and the American Heart Association outside the submitted work. One coauthor reported receiving grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development during the study. One coauthor reported receiving personal fees for serving on the board of directors for iRhythm and from fees paid through Cedars-Sinai Medical Center from Abbott Diagnostics and Sanofi outside the submitted work, and a coauthor reported serving as a clinical end point committee member for GlaxoSmithKline outside the submitted work. No other disclosures were reported. Dr Han has disclosed no relevant financial relationships.

JAMA Netw Open. 2022;5(12):e2248165.[1]

Study Highlights

  • nuMoM2b, a prospective, multicenter, cohort study, enrolled 10,038 women between October 1, 2010, and September 30, 2013.
  • The final analytic sample included 7,798 racially, ethnically, and geographically diverse women with singleton pregnancies and complete diet data.
  • Mean age was 27.4±5.5 years (9.7% aged 35 years and older); 10.5% were non-Hispanic Black, 16.6% were Hispanic, 19.5% had baseline obesity, 47.7% had educational level of bachelor’s degree and above, and 64.5% were married.
  • An Alternate Mediterranean Diet (aMed) score (range, 0-9; low, 0-3; moderate, 4-5; high, 6-9) was calculated from data on habitual diet in the 3 months around conception, using a semiquantitative food frequency questionnaire.
  • Mean aMed score was 4.3±2.1; prevalence of high, moderate, and low Mediterranean diet concordance around the time of conception was 30.6%, 31.2%, and 38.2%, respectively.
  • APOs were prospectively ascertained and defined as at least 1 of preeclampsia/eclampsia, gestational hypertension, gestational diabetes, preterm birth, delivery of a small-for-gestational-age infant, and/or stillbirth.
  • Women with higher aMed score were more likely older (mean 30.1±4.4 years), non-Hispanic White (77.7%), married (86.9%), never smokers (59.6%), of higher educational level (70.0%) and less likely obese (12.6%; P<.001 for all).
  • Participants in the high vs low aMed score category had lower overall prevalence of any APO (31.9% vs 38.2%), preeclampsia (6.1% vs 9.3%) and delivery of a small-for-gestational-age infant (8.8% vs 11.1%; P<.001 for all).
  • In multivariable models, high vs low aMed score was associated with 21% lower odds of any APO (adjusted odds ratio [aOR], 0.79; 95% CI, 0.68-0.92]), 28% lower odds of preeclampsia or eclampsia (aOR, 0.72; 95% CI, 0.55-0.93), and 37% lower odds of gestational diabetes (aOR, 0.63; 95% CI, 0.44-0.90).
  • Associations were stronger among women ages 35 years and older (aOR, 0.54; 95% CI, 0.34-0.84; P=.02 for interaction), but there were no differences by race, ethnicity, or prepregnancy body mass index.
  • Evaluation of aMed score quintiles yielded similar associations, with higher scores inversely associated with incidence of any APO.
  • aMed score was not significantly associated with odds of developing gestational hypertension, preterm birth, delivering a small-for-gestational-age infant, or stillbirth.
  • For aMed score components, plant-based foods and fish were inversely associated with APOs, but nut, whole-grain, fat, red meat, and alcohol component scores were not.
  • For preeclampsia/eclampsia, higher vegetable, fruit, and fish intakes were associated with lower risk, whereas higher intakes of vegetables and lower intakes of red and processed meat were associated with lower odds of gestational diabetes.
  • The investigators concluded that greater Mediterranean diet concordance was significantly associated with 21% lower risk of developing any APO and lower risk for multiple individual APOs in US women, with a dose-response association, as women with highest concordance before conception had lowest APO risk.
  • The findings add to the accumulating evidence that the Mediterranean diet, with higher intakes of vegetables, fruits, legumes, fish, and whole grains and lower intakes of red and processed meat, may be important in preserving women’s health across the lifespan, including during pregnancy.
  • As associations were similar among subgroups, the Mediterranean diet may benefit women of all racial and ethnic backgrounds, with and without obesity.
  • As lower-income women are less likely to be able to afford fresh produce and fish, policies enhancing equitable food distribution may be needed.
  • Associations between aMed score and developing preeclampsia/eclampsia and gestational diabetes are biologically plausible, as Mediterranean diet adherence has been linked to decreased adiposity; favorable glycemic profiles; lower systolic and diastolic blood pressure, inflammation, and insulin resistance; and better endothelial function, all implicated in preeclampsia and gestational diabetes.
  • Intervention studies are needed to determine whether promoting a Mediterranean-style diet around the time of conception and throughout pregnancy could prevent APOs and their downstream associations with future development of cardiovascular disease risk factors and overt disease.
  • Such studies should particularly include pregnant women at high risk for APOs, such as those with advanced maternal age.
  • Study limitations include reliance on self-report for diet; limited generalizability to women who are not married, non-Hispanic White, or less educated; observational design precluding causal inferences; and possible underestimation of the importance of the diet for APOs, as participants had access to prenatal care at a large academic medical center during the first 3 months of pregnancy.

Clinical Implications

  • Greater Mediterranean diet concordance was significantly associated with lower APO risk.
  • Intervention studies are needed to determine whether promoting a Mediterranean-style diet around the time of conception and throughout pregnancy could prevent APOs.
  • Implications for the Health Care Team: In order to best counsel women on the impact of diet on pregnancy outcomes, members of the healthcare team should be aware of the accumulating evidence that the Mediterranean diet pattern may help preserve women’s health across the lifespan.

 

Earn Credit

  • Print